Cardiac structural alterations in obese patients with or without metabolic syndrome and other cardiovascular risk factors.
Keywords:
Obesity, metabolic syndrome, ventricular geometry, Cardiovascular Risk FactorsAbstract
Obesity has become a serious health problem worldwide, being an independent risk factor for cardiovascular disease. In that sense, to evaluate the frequency of cardiac geometric alterations in obese patients with or without metabolic syndrome and other CV risk factors, a study was performed in 28 obese participants and 13 non-obese who went voluntarily to the Clinical Pharmacology Unit of the Dean of Health Sciences of UCLA who were given a questionnaire to determine other CV risk factors and had the following tests: triglycerides , Total and fractionated cholesterol, creatinine, fasting glycemia and insulin using the ELISA technique, and a transthoracic echocardiogram. The obese, sedentary population as a whole, showed significantly higher values in the dimensions of the interventricular septum (SVI), posterior wall of the left ventricle (PPVI), and left atrial diameter (AI); 25% of the obese population presented concentric remodeling and 4% had eccentric hypertrophy. 32.14% of the obese presented metabolic syndrome, 64.29% dyslipidemia, 21% arterial hypertension and 28.57% smoking habits. Conclusions: Mild left ventricular morphologic alterations were found in obese patients, the presence of smoking habits in males exacerbates such alterations
Keywords: Obesity, Cardiovascular Risk Factors, ventricular geometry
Downloads
References
2- Instituto Nacional de Nutrición. Sobrepeso y Obesidad en Venezuela (Prevalencia y factores condicionantes) [Libro en línea]. Colección Lecciones Institucionales. Fondo editorial Gente de Maíz, s/f. [Citado el 05 de Mayo de 2014] Disponible desde: http://www.inn.gob.ve/pdf/libros/sobrepeso.pdf
3- Schargrodsky H., Hernández-Hernández R., Champagne BM., Silva H., Vinueza R., Silva Ayçaguer LC. et al. CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med. 2008; 121(1):58-65.
4- Rocha IE, Victor EG, Braga MC, Barbosa e Silva O, Becker Mde M. Echocardiographics Evaluations for Asymptomatic Patients with Severe Obesity. Arq Bras Cardiol. 2007. 88 (1): 48-53.
5- Alpert MA., Chan EJ. Morfología ventricular izquierda y función diastólica en la obesidad grave: perspectivas actuales (editorial). Rev Esp Cardiol. 2012; 65 (1):1–3
6- Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005; 115:911-9
7- Yang R. and Barouch L. Leptin signaling and obesity: Cardiovascular Consequences. Circ Res. 2007; 101: 545-559.
8- Barouch LA, Berkowitz DE, Harrison RW, O’Donnell CP, Hare JM. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation. 2003; 108: 754-759
9- van der Kooy K. and Seidell JC. Techniques for the measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord. 1993 Apr;17(4):187-96
10- Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, et al. American Society of Echocardiography. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. 2015; 28 (1): 1–39.
11- Barrios Y, Carías D, Sánchez JA., Barón MA, Curiel S y Fernández M. Variables antropométricas que estiman adiposidad como predictores de resistencia a la insulina en mujeres posmenopáusicas con exceso de peso. Rev Venez Endocrinol Metab; 2013; 11(1): 9-17.
12- Gómez-García A, Nieto-Alcantar E, Gómez-Alonso C, Figueroa-Núñez B y Álvarez-Aguilar C. Parámetros antropométricos como predictores de resistencia a la insulina en adultos con sobrepeso y obesidad. Aten Primaria. 2010; 42(7):364–371.
13- Assmann G, Guerra R, Fox G, Cullen P, Schulte H, Willett D and Grundy SM. Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Am J Cardiol. 2007; 15:99(4):541-8.
14- Monami M, Marchionni N, Masotti G and Mannucci E. IDF and ATP definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients. Diabetes Obes Metab. 2007; 9(3):350-3.
15- Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 20 (16): 1640-5.
16- Abel ED, Litwin SE, Sweeney G. Cardiac remodeling in obesity. Physiol Rev. 2008; 88:380–419.
17- Alexander JK. The cardiomyopathy of obesity. Prog Cardiovasc Dis. 1985; 27(5): 325-34.
18- Zarich SW, Kowalchuk GJ, McGuire MP, Benotti PN, Mascioli EA, Nesto RW. Left ventricular filling abnormalities in asymptomatic morbid obesity. Am J Cardiol. 1991; 68(4): 377-81
19- Jiang ZY, Lin YW., Clemont A., Feener EP., Hein KD, Igarashi M, Yamauchi T, et al. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest. 1999; 104:447–57
20- Minicucci M, Oliveira F, Santos P, Polegato B, Roscani M, Fernandes AA, et al. Pentoxifylline Attenuates Cardiac Remodeling Induced by Tobacco Smoke Exposure.Arq Bras Cardiol. 2016 May;106(5):396-403
21- Gu L, Pandey V, Geenen DL, Chowdhury SA, Piano MR. Cigarette smoke-induced left ventricular remodelling is associated with activation of mitogen-activated protein kinases. Eur J Heart Fail. 2008;10(11):1057
22- Novo R, Freire CM, Felisbino S, Minicucci MF, Azevedo PS, Zornoff LA, et al. Smoking is associated with remodeling of gap junction in the rat heart: smoker's paradox explanation? Arq Bras Cardiol. 2013; 100(3):274–280.
Published
How to Cite
Issue
Section
Derechos del/de autor/es a partir del año de publicación
Esta obra está bajo la licencia:
Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
Las opiniones expresadas por los autores no necesariamente reflejan la postura del editor de la publicación ni de la UCLA. Se autoriza la reproducción total o parcial de los textos aquí publicados, siempre y cuando se cite la fuente completa y la dirección electrónica de esta revista. Los autores(as) tienen el derecho de utilizar sus artículos para cualquier propósito siempre y cuando se realice sin fines de lucro. Los autores(as) pueden publicar en internet o cualquier otro medio la versión final aprobada de su trabajo, luego que esta ha sido publicada en esta revista.
